People

Mert Sahin, PhD, was appointed CEO of Durin Technologies in a November22,2023 issuer release and signed its March2025 equity amendment as CEO. He led the business during the2023 funding announcement. The July2025 SEC amendment instead names Maribeth Bluyus CEO; exact employment end date is unknown. No current Durin CEO appointment or personal investment is inferred.

Roles

Durin Life Sciences

Chief Executive Officer (historical:November2023–March2025 published disclosures)

Current